Tazarotene.. Antipsoriatic, antiacne, retinoid

Drugs of the Future

Volumn 22, Issue 3, 1997, Pages 249-255

  Ngo, J ^a   Leeson, P A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ACNE AGENT; ANTIPSORIASIS AGENT; FLUOCINONIDE; RETINOIC ACID RECEPTOR; RETINOID; TAZAROTENE;

ACNE VULGARIS; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; NONHUMAN; PRURITUS; PSORIASIS; SHORT SURVEY; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030927216     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.03.399408     Document Type: Short Survey

References (35)

1. Chandraratna, R.A.S. (Allergan, Inc.). Disubstd. acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. US 5089509.
2. Chandraratna, R.A.S. (Allergan, Inc.). Disubstd. acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. EP 284288, JP 88255277, JP 95324085.
3. Chandraratna, R.A.S. (Allergan, Inc.). Disubstd. acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. WO 9611686.
4. Weinstein, G.D., Krueger, J.G. Therapy of moderate-to-severe psoriasis. National Psoriasis Foundation, 1993, 3.
5. Weinstein, G.D., Krueger, J.G. Therapy of moderate-to-severe psoriasis. National Psoriasis Foundation, 1993, 19.
6. Drake, L.A., Ceilly, R.I., Cornelison, R.L. et al. Guidelines of care for psoriasis. J Amer Acad Dermatol 1993, 28: 632-7.
7. Drake, L.A., Ceilly, R.I., Dorner, W., Goltz, R.W., Graham, G.F., Lewis, C.W., Salasche, S.J., Turner, M.L.C., Lowery, B.J. Guidelines of care for phototherapy and photochemotherapy. J Amer Acad Dermatol 1994, 31: 643-8.
8. Frost, P.F., Weinstein, G.D. Topical administration of vitamin A acid for ichthyosiform dermatoses and psoriasis. J Amer Med Assoc 1969, 206: 1863-8.
9. Fredriksson, T. Antipsoriatic activity of retinoic acid (vitamin A acid). Dermatologica 1971, 142: 113-6.
10. MacDonald, A., McMinn, R.M.H., Fry, L. Effect of retinoic acid in psoriasis. II: Long term study. Brit J Dermatol 1972, 87: 256-60.
11. Orfanos, C.E., Schmidt, H.W., Mahrle, G. et al. Retinoic acid in psoriasis: Its value for topical therapy with and without corticosteroids. Clinical, histological, and electron microscopical studies on forty-four hospitalized patients with extensive psoriasis. Brit J Dermatol 1973, 88: 167-82.
12. Günther, S. The therapeutic value of retinoic acid in chronic, acute, guttate, and erythrodermic psoriasis: Clinical observations on twenty-five patients. Brit J Dermatol 1973, 89: 515-7.
13. Bischoff, R., De Jong, E.M.G.J., Rulo, H.F.C. et al. Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis. Clin Exp Dermatol 1992, 17: 9-12.
14. Chandraratna, R.A.S., Marier, D.K., Garst, M.E., Gil, D., Wheeler, L., Lew-Kaya, D., Sefton, J., Duvic, M. Receptor specific retinoids for the topical treatment of psoriasis. 204th ACS Natl Meet (Aug 23-28, Washington DC) 1992, Abst MEDI 5.
15. Chandraratna, R.A.S. Tazarotene - First of a new generation of receptor-selective retinoids. Brit J Dermatol 1996, 135: 18-25.
16. Duvic, M. Molecular mechanisms of tazarotene action in psoriasis. Clin Dermatol 2000 (May 28-31, Vancouver) 1996, Abst 9.
17. Matsumoto, R.M., Sun, H., Duff, S.B., Tang-Liu, D. Skin distribution and metabolism of 14C-AGN 190168 in minipigs. Pharm Res 1992, 9(10, Suppl.): Abst PPDM 8131.
18. Matsumoto, R.M., Sun, H., Tang-Liu, D. Species correlation of AGN 190168 disposition in mouse, hamster, rat, rabbit, monkey and man. Pharm Res 1992, 9(10, Suppl.): Abst PPDM 8070.
19. Fritsch, P.O. Retinoids in psoriasis and disorders of keratinization. J Amer Acad Dermatol 1992, 27: S8-14.
20. Hsyu, P.-B., Bowen, B., Tang-Liu, D. Pharmacokinetics of a novel retinoid AGN 190168 and its metabolite AGN 190299 after intravenous administration of AGN 190168 to rats. Biopharm Drug Dispos 1994, 15: 347-57.
21. Chien, D.-S., Sandri, R.B., Tang-Liu, D.D.-S. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats. Drug Metab Dispos 1992, 20: 211-7.
22. DiGiovanna, J.J., Zech, L.A., Ruddel, M.E., Gantt, G., Peck, G.L. Etretinate: Persistent serum levels after long-term therapy. Arch Dermatol 1989, 125: 246-51.
23. Franz, T.J., Lehman, P.A., Franz, S., Lew-Kaya, D.A., Matsumoto, R., Tang-Liu, D. Percutaneous absorption of AGN 190168, a new synthetic retinoid, through human skin in-vivo. Clin Res 1992, 40: 533A.
24. Matsumoto, R.M., Tang-Liu, D., Lew-Kaya, D., Sefton, J. Pharmacokinetics of AGN 190168, a novel retinoid, after topical dosing of a 0.1% or 0.05% gel in healthy male volunteers. Pharm Res 1994, 11(10, Suppl.): Abst PPDM 8141.
25. Marks, R. Early clinical development of tazarotene. Brit J Dermatol 1996, 135(Suppl. 49): 26-31.
26. Esgleyes-Ribot, T., Chandraratna, R.A., Lew-Kaya, D.A., Sefton, J., Duvic, M. Response of psoriasis to a new topical retinoid, AGN 190168. J Amer Acad Dermatol 1994, 30: 581-90.
27. Weinstein, G.D. Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Brit J Dermatol 1996, 135(Suppl. 49): 32-6.
28. Weinstein, G.D. Tazarotene gel: Effective treatment for plaque psoriasis. Clin Dermatol 2000 (May 28-31, Vancouver) 1996, Abst 11.
29. Weinstein, G., Jeffes, E., Duvic, M. et al. Tazarotene gel for the treatment of plaque psoriasis: A double-blind clinical study. Clin Dermatol 2000 (May 28-31, Vancouver) 1996, Abst 351.
30. Ast, E., Callen, J., Cullen, S. et al. Tazarotene 0.1% and 0.05% gels compared with fluocinonide 0.05% cream in the treatment of plaque psoriasis: An investigator-masked study of safety, efficacy, and duration of therapeutic effect. Clin Dermatol 2000 (May 28-31, Vancouver) 1996, Abst 353.
31. Marks, R. Clinical safety of tazarotene in the treatment of plaque psoriasis. Clin Dermatol 2000 (May 28-31, Vancouver) 1996, Abst 10.
32. Drake, L., Duvic, M., Elias, P. et al. Tazarotene: A novel retinoid gel for the treatment of plaque psoriasis. Clin Dermatol 2000 (May 28-31, Vancouver) 1996, Abst 352.
33. Shalita, A.R., Chalker, D.K., Griffith, R.F. et al. Double-blind study of AGN 190168, a new retinoid gel, in the topical treatment of acne vulgaris. Clin Res 1993, 41: 424A.
34. First marketing approval for Allergan antipsoriatic. Prous Science Daily Essentials, December 13, 1996 (http://www.prous.com/ home_daily).
35. Zorac available in Germany. Prous Science Daily Essentials, March 12, 1997 (http://www.prous.com/home_daily).